Ivan Correa

Dr. Ivan Correa

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Chemistry & Biology
Verified
Journal Article
Closed access
AGArnaud Gautier
Arnaud Gautier
AJAlexandre Juillerat
Alexandre Juillerat
CHChristian Heinis
Christian Heinis
ICIvan Correa
Ivan Correa
MKMaik Kindermann
Maik Kindermann
KJKai Johnsson
Kai Johnsson

6 January 2013 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
GLGrazvydas Lukinavicius
Grazvydas Lukinavicius
KUKeitaro Umezawa
Keitaro Umezawa
NONicolas Olivier
Nicolas Olivier
AHAlf Honigmann
Alf Honigmann
GYGuoying Yang
Guoying Yang
KJKai Johnsson
Kai Johnsson

7 May 2014 in Nature
Verified
Journal Article
Open access
PDF file
DMDenis A. Malyshev
Denis A. Malyshev
KDKirandeep Dhami
Kirandeep Dhami
TLThomas Lavergne
Thomas Lavergne
TCTingjian Chen
Tingjian Chen
NDNan Dai
Nan Dai
FRFloyd E. Romesberg
Floyd E. Romesberg
Triphosphates of hydrophobic nucleotides d5SICS and dNaM are imported into Escherichia coli by an exogenous algal nucleotide triphosphate transporter and then used by an endogenous polymerase to replicate, and faithfully maintain over many generations of growth, a plasmid containing the d5SICS–dNaM unnatural base pair. The genetic code is simple: four bases that form two pairs (A–T and G–C) are used in all of life. Expansion of this code to incorporate unnatural nucleotides and base pairing has been a goal of synthetic biology, as it would open up ways to tailor organisms for directed purposes. Although this has been achieved in proof-of-principle experiments in vitro, stable propagation of an expanded code had not been demonstrated in vivo until now. Floyd Romesberg and colleagues present evidence that two hydrophobic nucleotides, d5SICSTP and dNaMTP, can be added to the medium in which Escherichia coli expressing an exogenous algal nucleotide triphosphate transporter is growing, and that these nucleotides will be incorporated in the genome and are not recognized as lesions by the repair pathway. Consequently, the unnatural-base-pair-containing DNA is replicated, without cell growth being significantly affected. Organisms are defined by the information encoded in their genomes, and since the origin of life this information has been encoded using a two-base-pair genetic alphabet (A–T and G–C). In vitro, the alphabet has been expanded to include several unnatural base pairs (UBPs)1,2,3. We have developed a class of UBPs formed between nucleotides bearing hydrophobic nucleobases, exemplified by the pair formed between d5SICS and dNaM (d5SICS–dNaM), which is efficiently PCR-amplified1 and transcribed4,5 in vitro, and whose unique mechanism of replication has been characterized6,7. However, expansion of an organism’s genetic alphabet presents new and unprecedented challenges: the unnatural nucleoside triphosphates must be available inside the cell; endogenous polymerases must be able to use the unnatural triphosphates to faithfully replicate DNA containing the UBP within the complex cellular milieu; and finally, the UBP must be stable in the presence of pathways that maintain the integrity of DNA. Here we show that an exogenously expressed algal nucleotide triphosphate transporter efficiently imports the triphosphates of both d5SICS and dNaM (d5SICSTP and dNaMTP) into Escherichia coli, and that the endogenous replication machinery uses them to accurately replicate a plasmid containing d5SICS–dNaM. Neither the presence of the unnatural triphosphates nor the replication of the UBP introduces a notable growth burden. Lastly, we find that the UBP is not efficiently excised by DNA repair pathways. Thus, the resulting bacterium is the first organism to propagate stably an expanded genetic alphabet.

17 June 2021 in Genome Research
Verified
Journal Article
Open access
PDF file
RVRomualdas Vaisvila
Romualdas Vaisvila
VPV.K. Chaithanya Ponnaluri
V.K. Chaithanya Ponnaluri
ZSZhiyi Sun
Zhiyi Sun
BLBradley William Langhorst
Bradley William Langhorst
LSLana Saleh
Lana Saleh
TDTheodore B. Davis
Theodore B. Davis
Bisulfite sequencing detects 5mC and 5hmC at single-base resolution. However, bisulfite treatment damages DNA, which results in fragmentation, DNA loss, and biased sequencing data. To overcome these problems, enzymatic methyl-seq (EM-seq) was developed. This method detects 5mC and 5hmC using two sets of enzymatic reactions. In the first reaction, TET2 and T4-BGT convert 5mC and 5hmC into products that cannot be deaminated by APOBEC3A. In the second reaction, APOBEC3A deaminates unmodified cytosines by converting them to uracils. Therefore, these three enzymes enable the identification of 5mC and 5hmC. EM-seq libraries were compared with bisulfite-converted DNA, and each library type was ligated to Illumina adaptors before conversion. Libraries were made using NA12878 genomic DNA, cell-free DNA, and FFPE DNA over a range of DNA inputs. The 5mC and 5hmC detected in EM-seq libraries were similar to those of bisulfite libraries. However, libraries made using EM-seq outperformed bisulfite-converted libraries in all specific measures examined (coverage, duplication, sensitivity, etc.). EM-seq libraries displayed even GC distribution, better correlations across DNA inputs, increased numbers of CpGs within genomic features, and accuracy of cytosine methylation calls. EM-seq was effective using as little as 100 pg of DNA, and these libraries maintained the described advantages over bisulfite sequencing. EM-seq library construction, using challenging samples and lower DNA inputs, opens new avenues for research and clinical applications.

26 July 2011 in ChemBioChem
Verified
Journal Article
Open access
PDF file
XSXiaoli Sun
Xiaoli Sun
AZAihua Zhang
Aihua Zhang
BBBrenda Baker
Brenda Baker
LSLuo Sun
Luo Sun
AHAngela Howard
Angela Howard
ICIvan Correa
Ivan Correa
The ability to specifically attach chemical probes to individual proteins represents a powerful approach to the study and manipulation of protein function in living cells. It provides a simple, robust and versatile approach to the imaging of fusion proteins in a wide range of experimental settings. However, a potential drawback of detection using chemical probes is the fluorescence background from unreacted or nonspecifically bound probes. In this report we present the design and application of novel fluorogenic probes for labeling SNAP‐tag fusion proteins in living cells. SNAP‐tag is an engineered variant of the human repair protein O6‐alkylguanine‐DNA alkyltransferase (hAGT) that covalently reacts with benzylguanine derivatives. Reporter groups attached to the benzyl moiety become covalently attached to the SNAP tag while the guanine acts as a leaving group. Incorporation of a quencher on the guanine group ensures that the benzylguanine probe becomes highly fluorescent only upon labeling of the SNAP‐tag protein. We describe the use of intramolecularly quenched probes for wash‐free labeling of cell surface‐localized epidermal growth factor receptor (EGFR) fused to SNAP‐tag and for direct quantification of SNAP‐tagged β‐tubulin in cell lysates. In addition, we have characterized a fast‐labeling variant of SNAP‐tag, termed SNAPf, which displays up to a tenfold increase in its reactivity towards benzylguanine substrates. The presented data demonstrate that the combination of SNAPf and the fluorogenic substrates greatly reduces the background fluorescence for labeling and imaging applications. This approach enables highly sensitive spatiotemporal investigation of protein dynamics in living cells.

23 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
BJBen Jones
Ben Jones
TBTeresa Buenaventura
Teresa Buenaventura
NKNisha Kanda
Nisha Kanda
PCPauline Chabosseau
Pauline Chabosseau
BOBryn M. Owen
Bryn M. Owen
SBStephen R. Bloom
Stephen R. Bloom
Glucagon-like peptide-1 receptor (GLP-1R) activation promotes insulin secretion from pancreatic beta cells, causes weight loss, and is an important pharmacological target in type 2 diabetes (T2D). Like other G protein-coupled receptors, the GLP-1R undergoes agonist-mediated endocytosis, but the functional and therapeutic consequences of modulating GLP-1R endocytic trafficking have not been clearly defined. Here, we investigate a series of biased GLP-1R agonists with variable propensities for GLP-1R internalization and recycling. Compared to a panel of FDA-approved GLP-1 mimetics, compounds that retain GLP-1R at the plasma membrane produce greater long-term insulin release, which is dependent on a reduction in β-arrestin recruitment and faster agonist dissociation rates. Such molecules elicit glycemic benefits in mice without concomitant increases in signs of nausea, a common side effect of GLP-1 therapies. Our study identifies a set of agents with specific GLP-1R trafficking profiles and the potential for greater efficacy and tolerability as T2D treatments.